These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 389724)

  • 1. Effect of pharmacological agents and fasting on pancreatic islet norepinephrine in the golden hamster.
    Feldman JM; Henderson JH; Blalock JA
    Diabetologia; 1979 Sep; 17(3):169-74. PubMed ID: 389724
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster.
    Zern RT; Bird JL; Feldman JM
    Diabetologia; 1980 Apr; 18(4):341-6. PubMed ID: 6998806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golden hamster pancreatic islets: a tissue rich in monoamine oxidase.
    Feldman JM; White-Owen C; Klatt C
    Endocrinology; 1980 Nov; 107(5):1504-11. PubMed ID: 7000496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas.
    Feldman JM; Reintgen DS; Seigler HF
    Diabetologia; 1979 Oct; 17(4):249-56. PubMed ID: 227764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of monoamine oxidase in golden hamster islets and insulinoma.
    Feldman JM; Castleberry CA; Vervaert C; Seigler HF
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):307-20. PubMed ID: 6308735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography.
    Lundquist I; Ahrén B; Hansson C; Håkanson R
    Pancreas; 1989; 4(6):662-7. PubMed ID: 2682605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes mellitus and chemical sympathectomy on tissue monoamine oxidase activity and norepinephrine concentration in the golden hamster.
    Quansah FA; Klatt C; Feldman JM
    Metabolism; 1981 Mar; 30(3):242-7. PubMed ID: 7010072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of noradrenaline and of monoamine oxidase and catechol-O-methyltransferase activity in human foetal heart.
    Gennser G; Rosengren E; von Studnitz W
    Experientia; 1973 May; 29(1):20-2. PubMed ID: 4729439
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of the dopaminergic and noradrenergic systems of the pancreatic islets.
    Zern RT; Foster LB; Blalock JA; Feldman JM
    Diabetes; 1979 Mar; 28(3):185-9. PubMed ID: 376376
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tranylcypromine and iproniazid on brain amine levels and ovulation in the golden hamster.
    Alleva JJ; Overpeck JG; Umberger EJ
    Life Sci; 1966 Sep; 5(17):1557-61. PubMed ID: 6008165
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies on a new analgesic drug, 1-(m-methoxyphenyl)-2-dimethylaminomethyl cyclohexanol (1) hydrochloride (K-315). 4. Catecholamine potentiating effects of K-315].
    Henmi Z
    Nihon Yakurigaku Zasshi; 1973 May; 69(3):447-58. PubMed ID: 4739064
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic islets: a tissue rich in serotonin.
    Bird JL; Wright EE; Feldman JM
    Diabetes; 1980 Apr; 29(4):304-8. PubMed ID: 6987120
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of pancreatic islet monoamine oxidase.
    Feldman JM; Chapman B
    Metabolism; 1975 May; 24(5):581-8. PubMed ID: 1092954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels.
    Spector S; Tarver J; Berkowitz B
    Pharmacol Rev; 1972 Jun; 24(2):191-202. PubMed ID: 4405384
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.
    Bressler R; Vargas-Cord M; Lebovitz HE
    Diabetes; 1968 Oct; 17(10):617-24. PubMed ID: 4878653
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretion.
    Feldman JM; Chapman BA; Plonk JW
    Life Sci; 1974 Sep; 15(6):1121-34. PubMed ID: 4157278
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function.
    Liang Y; Luo S; Cincotta AH
    Metabolism; 1999 Oct; 48(10):1287-9. PubMed ID: 10535392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of cardiac noradrenaline depletion in human congestive failure.
    Dequattro V; Nagatsu T; Mendez A; Verska J
    Cardiovasc Res; 1973 May; 7(3):344-50. PubMed ID: 4146654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.